Board Meetings for JUBLPHARMA
Detailed list of historic and upcoming board meetings.
| Symbol | Company | Meeting Date | Purpose | Description | Links |
|---|---|---|---|---|---|
| JUBLPHARMA | Jubilant Pharmova Limited | 04 Feb 2022 | Financial Results | To consider and approve the financial results for the period ended December 31, 2021 | |
| JUBLPHARMA | Jubilant Pharmova Limited | 22 Oct 2021 | Financial Results | To consider and approve the financial results for the period ended September 30, 2021 | |
| JUBLPHARMA | Jubilant Pharmova Limited | 23 Jul 2021 | Financial Results | To consider and approve the financial results for the period ended Jun 30, 2021 | |
| JUBLPHARMA | Jubilant Pharmova Limited | 04 Jun 2021 | Financial Results/Dividend | To consider and approve the financial results for the period ended March 31, 2021 and dividend | |
| JUBLPHARMA | Jubilant Pharmova Limited | 05 Feb 2021 | Financial Results | To consider and approve the financial results for the period ended December 31, 2020 | |
| JUBLPHARMA | Jubilant Pharmova Limited | 04 Nov 2020 | Financial Results/Fund Raising | To consider and approve the financial results for the quarter and half year ended September 30, 2020 and Issue of Non-Convertible Debentures | |
| JUBLPHARMA | Jubilant Pharmova Limited | 04 Sept 2020 | Financial Results | To consider and approve the financial results for the period ended Jun 30, 2020.In terms of Regulation 29 of the Securities and Exchange Board of India (Listing Obligations and Disclosure Requirements) Regulations, 2015 (the Listing Regulations ), we wish to inform you that a meeting of the Board of Directors of the Company is scheduled to be held on Friday, September 4, 2020, to inter-alia consider Unaudited Standalone and Consolidated Financial Results of the Company for the quarter ended June 30, 2020.This is for information and record. | |
| JUBLPHARMA | Jubilant Pharmova Limited | 29 May 2020 | Financial Results/Fund Raising | In terms of Regulation 29 of the Securities and Exchange Board of India (Listing Obligations and Disclosure Requirements) Regulations, 2015, we wish to inform you that a meeting of the Board of Directors of the Company is scheduled to be held on Friday, May 29, 2020, to inter-alia consider:��1. Audited Standalone and Consolidated Financial Results of the Company for the quarter and year ended March 31, 2020.��2. Issue of Non-Convertible Debentures upto Rs. 100 Crore.This is for information and record. | |
| JUBLPHARMA | Jubilant Pharmova Limited | 27 Feb 2020 | Dividend | To consider interim dividend for FY 2019-20 | |
| JUBLPHARMA | Jubilant Pharmova Limited | 31 Jan 2020 | Financial Results | In terms of Regulation 29 of the Securities and Exchange Board of India (Listing Obligations and Disclosure Requirements) Regulations, 2015 (the Listing Regulations ), we wish to inform you that a meeting of the Board of Directors of the Company is scheduled to be held on Friday, January 31, 2020, to inter-alia consider Unaudited Standalone and Consolidated Financial Results of the Company for the quarter ended December 31, 2019.This is for information and record. | |
| JUBLPHARMA | Jubilant Pharmova Limited | 25 Oct 2019 | Financial Results | To consider and approve the financial results for the period ended September 30, 2019 | |
| JUBLPHARMA | Jubilant Pharmova Limited | 26 Jul 2019 | Financial Results | To consider and approve the financial results for the period ended Jun 30, 2019 | |
| JUBLPHARMA | Jubilant Pharmova Limited | 17 May 2019 | Financial Results/Dividend | To consider and approve the financial results for the period ended March 31, 2019 and dividend | |
| JUBLPHARMA | Jubilant Pharmova Limited | 01 Feb 2019 | Financial Results | In terms of Regulation 29 of the Securities and Exchange Board of India (Listing Obligations and Disclosure Requirements) Regulations, 2015 (the ��Listing Regulations��), we wish to inform you that a meeting of the Board of Directors of the Company is scheduled to be held on Friday, February 1, 2019, to inter-alia consider Unaudited Standalone and Consolidated Financial Results of the Company for the quarter ended December 31, 2018.This is for information and record. | |
| JUBLPHARMA | Jubilant Pharmova Limited | 22 Oct 2018 | Financial Results | To consider and approve the financial results for the period ended September 30, 2018 |